{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/moh-stock-analysis/",
 "dataUrl": "https://clearank.com/stock/moh-stock-analysis/data.json",
 "title": "Molina Healthcare (MOH) Stock Forecast & Price Target (2026)",
 "description": "Molina Healthcare Inc. (MOH) stock: Healthcare, Healthcare Plans. $10.0B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Molina Healthcare Inc. (MOH)",
 "published": "2026-07-23T09:31:38+00:00",
 "modified": "2026-09-27T05:26:20.963+00:00",
 "generated": "2026-09-27T15:54:19.485Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "MOH",
  "name": "Molina Healthcare Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Healthcare Plans",
  "country": "United States",
  "website": "https://www.molinahealthcare.com"
 },
 "quote": {
  "price": 190.86,
  "previousClose": 193.31,
  "change": -2.45,
  "changePercent": -1.27,
  "open": 193.59,
  "high": 195.81,
  "low": 189.32001,
  "volume": 676400,
  "averageVolume": 607110,
  "marketCap": 9962892000,
  "fiftyTwoWeekHigh": 244.89,
  "fiftyTwoWeekLow": 121.059998,
  "marketOpen": false,
  "asOf": "2026-09-27T05:26:20.000Z"
 },
 "statistics": {
  "pe": 1272.3999,
  "eps": 0.15,
  "dividendYield": 0,
  "beta": 0.755,
  "priceToSales": 0.23459211,
  "priceToBook": 2.3794446,
  "revenueTtm": 42468999168,
  "grossMargin": 0.08543314327754276,
  "returnOnEquity": -0.0016
 },
 "technicals": {
  "rsi": 42.17,
  "macd": -2.56,
  "sma50": 201.53,
  "sma200": 181.1,
  "rsiSignal": "Neutral",
  "trend": "Bullish",
  "pricePosition": "Bearish",
  "macdSignal": "Bearish",
  "rating": "Bearish"
 },
 "analysis": {
  "rating": "Hold",
  "score": 54,
  "consensus": "Hold",
  "fairValue": 209,
  "analystTarget": 209,
  "analystCount": 19,
  "wallStreetConsensus": "Hold",
  "generatedAt": "2026-09-27T05:26:20.000Z",
  "priceAtAnalysis": 190.86,
  "volatility": {
   "daily": 2.07,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Neutral",
  "conservativeEntry": 188.95,
  "aggressiveEntry": 190.86,
  "stopLoss": 179.24,
  "stopLossPercent": 5.14,
  "targets": [
   194.62,
   198.4,
   204.07
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 123.25,
    "base": 209.68,
    "upside90th": 356.72
   },
   {
    "year": 2028,
    "downside10th": 108.65,
    "base": 230.36,
    "upside90th": 488.38
   },
   {
    "year": 2029,
    "downside10th": 100.82,
    "base": 253.07,
    "upside90th": 635.25
   },
   {
    "year": 2030,
    "downside10th": 96.06,
    "base": 278.03,
    "upside90th": 804.68
   },
   {
    "year": 2031,
    "downside10th": 93.09,
    "base": 305.44,
    "upside90th": 1002.17
   },
   {
    "year": 2032,
    "downside10th": 91.31,
    "base": 335.56,
    "upside90th": 1233.21
   },
   {
    "year": 2033,
    "downside10th": 90.38,
    "base": 368.65,
    "upside90th": 1503.73
   },
   {
    "year": 2034,
    "downside10th": 90.11,
    "base": 405.01,
    "upside90th": 1820.41
   },
   {
    "year": 2035,
    "downside10th": 90.37,
    "base": 444.94,
    "upside90th": 2190.81
   },
   {
    "year": 2036,
    "downside10th": 91.07,
    "base": 488.82,
    "upside90th": 2623.59
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "MOH Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$193.59",
    "Day Range": "$189.32 to $195.81",
    "Prev Close": "$193.31",
    "Volume": "676.4K",
    "52-Week Range": "$121.06 to $244.89",
    "Market Cap": "$9.96B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Trading at a significant premium to sector peers (+3,889%), suggesting market expectations for superior growth or market position."
   ]
  },
  {
   "id": "financials",
   "title": "MOH Financial Performance"
  },
  {
   "id": "analysis",
   "title": "MOH Analysis",
   "text": [
    "Molina Healthcare Inc. (MOH) is trading below its 50-day SMA of $201.53 and its 20-day EMA of $198.54, indicating a bearish short-term trend. The Relative Strength Index (RSI) is at 42.17, reflecting neutral momentum, while the MACD is negative at -2.56, suggesting downward pressure. The 200-day SMA at $181.10 represents a significant longer-term floor. Volume has been slightly above average recently, with the latest volume at 676,400 compared to an average of 607,110, suggesting some investor interest but not overwhelming conviction. The current price action suggests a potential for further downside towards the 200-day SMA if the bearish momentum continues.",
    "Insiders have sold $32.7 million worth of stock against only $1.7 million in purchases, indicating a lack of confidence in the near-term outlook.",
    "MOH is trading below its 50-day SMA ($201.53) and 20-day EMA ($198.54), suggesting a bearish short-term trend and potential for further price declines.",
    "Wall Street expects EPS to grow by 85.6% next year, signaling a significant turnaround from current negative profitability.",
    "Revenue growth is expected to shift from -2.00% this year to +8.00% next year, indicating a recovery in the company's top line.",
    "Molina Healthcare Inc. (MOH) is expected to see a significant recovery in earnings and revenue over the next year, with EPS projected to grow by 85.6% and revenue by 8.00%. The median analyst price target of $209.00 suggests that the market anticipates this turnaround, offering a modest upside from the current price. The company's long-term growth prospects, estimated at 35.6% annually over the next five years, are strong. However, the path to achieving these projections is fraught with near-term challenges. The stock's current technical setup is bearish, trading below key moving averages, and significant insider selling indicates caution. The company's current unprofitability and higher-than-sector debt levels present risks that could derail the anticipated recovery if not managed effectively. Investors should monitor upcoming earnings reports for confirmation of the projected growth trajectory and profitability improvements."
   ],
   "lists": {
    "ProTips": [
     "Insider selling activity totaling $32.7 million warrants close attention, suggesting potential near-term headwinds for MOH stock.",
     "The stock's position below its 50-day and 20-day moving averages indicates a bearish technical trend, advising caution for new positions.",
     "Given the current unprofitability and negative profit margins, investors should closely monitor forward-looking earnings estimates and revenue growth projections for signs of sustained recovery."
    ]
   },
   "catalysts": [
    {
     "type": "Bearish",
     "title": "Significant Insider Selling Pressure",
     "text": "Insiders have sold $32.7 million worth of stock against only $1.7 million in purchases, indicating a lack of confidence in the near-term outlook.",
     "source": "Insider Transactions"
    },
    {
     "type": "Bearish",
     "title": "Technical Downtrend Confirmation",
     "text": "MOH is trading below its 50-day SMA ($201.53) and 20-day EMA ($198.54), suggesting a bearish short-term trend and potential for further price declines.",
     "source": "Technical Analysis"
    },
    {
     "type": "Bullish",
     "title": "Strong Forward EPS Growth Estimates",
     "text": "Wall Street expects EPS to grow by 85.6% next year, signaling a significant turnaround from current negative profitability.",
     "source": "Wall Street Estimates"
    },
    {
     "type": "Bullish",
     "title": "Projected Revenue Rebound",
     "text": "Revenue growth is expected to shift from -2.00% this year to +8.00% next year, indicating a recovery in the company's top line.",
     "source": "Wall Street Estimates"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Molina Healthcare Inc. (MOH) exhibits a high Price-to-Earnings ratio of 1272.40 and a Price-to-Sales ratio of 0.23, which appears inexpensive relative to its sector's median P/S of 3.7, but its P/E is significantly higher than the sector median of 31.9. The company is currently loss-making, with a negative profit margin of -0.02% and a negative return on equity of -0.16%, contrasting sharply with the sector's median ROE of 6.9%. Despite the current profitability challenges, forward-looking estimates suggest a significant turnaround. Wall Street expects EPS to grow from a current year estimate of $5.25 to $8.55 next year, and revenue growth is projected to rebound from -2.00% this year to +8.00% next year. The company's debt-to-equity ratio stands at 0.95, which is higher than the sector median, indicating a more leveraged capital structure. The current valuation appears to be pricing in substantial future growth, which is not yet reflected in current operational performance.",
    "Molina Healthcare Inc. (MOH) faces a challenging earnings environment, with current year EPS estimates at $5.25, a significant decrease from $11.03 in the prior year. Wall Street revenue estimates also show a slight contraction for the current year at -2.00%, though a strong rebound is projected for next year. The company's profit margin is currently negative at -0.02%, indicating it is not generating profits on its revenue. Forward-looking growth estimates are positive, with next year's EPS projected to increase by 85.6% and revenue by 8.00%, suggesting a strong recovery is anticipated.",
    "Molina Healthcare Inc. (MOH) faces significant risks including its current unprofitability, evidenced by a negative profit margin and return on equity. The moderate sell signal from insider transactions, with $32.7 million in sales versus $1.7 million in purchases, suggests a lack of insider confidence in the near term. Also, the stock is trading below key short-term moving averages, indicating potential for further price depreciation."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "9.96B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "1,272.40"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "0.1500"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.00%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "244.89"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "121.06"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bearish RSI Neutral SMA Cross Bullish Price vs SMA Bearish MACD Bearish Golden Cross in effect with the 50-day SMA ($201.53) above the 200-day SMA ($181.10), price is trading below the 50-day SMA."
   ],
   "facts": {
    "RSI": "Neutral",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bearish",
    "MACD": "Bearish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "42.17"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "-2.56"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "201.53"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "181.10"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.01",
    "Correlation with Nasdaq 100 (QQQ)": "-0.03",
    "Correlation with Bitcoin (BTC)": "+0.23",
    "Correlation with Gold (XAU)": "-0.06"
   }
  },
  {
   "id": "trade-plans",
   "title": "MOH Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Enter now if confident",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (42.2) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$194.62",
    "TARGET 2": "$198.40",
    "TARGET 3": "$204.07",
    "STOP LOSS": "$179.24"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+2.60%",
    "Average Feb return": "-5.67%",
    "Average Mar return": "+2.97%",
    "Average Apr return": "+6.34%",
    "Average May return": "+1.24%",
    "Average Jun return": "+4.07%",
    "Average Jul return": "-2.26%",
    "Average Aug return": "+2.69%",
    "Average Sep return": "+1.43%",
    "Average Oct return": "-2.48%",
    "Average Nov return": "+3.22%",
    "Average Dec return": "+1.52%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "2.07%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in MOH in September 2016 would be worth about $32,856 today, compared with about $35,782 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MOH today could grow to about $25,611 by 2036 in the base case, with a bull case near $137,462 and a bear case around $4,772. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "MOH Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $278 for MOH by 2030 in the base case, from $191 today (1.5x over 4 years). The downside path ends near $96.06. These are outcomes of a Monte Carlo simulation run on MOH's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using MOH's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "MOH simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$123",
        "$210",
        "$357"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$109",
        "$230",
        "$488"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$101",
        "$253",
        "$635"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$96.06",
        "$278",
        "$805"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$93.09",
        "$305",
        "$1,002"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$91.31",
        "$336",
        "$1,233"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$90.38",
        "$369",
        "$1,504"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$90.11",
        "$405",
        "$1,820"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$90.37",
        "$445",
        "$2,191"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$91.07",
        "$489",
        "$2,624"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "CAPR Capricor Therapeutics, Inc. NASDAQ $8.36 -2.45%",
     "url": "https://clearank.com/stock/capr-stock-analysis/"
    },
    {
     "text": "NEOG Neogen Corp. NASDAQ $13.76 +0.73%",
     "url": "https://clearank.com/stock/neogen-neog/"
    },
    {
     "text": "RXRX Recursion Pharmaceuticals, Inc. NASDAQ $3.74 -3.86%",
     "url": "https://clearank.com/stock/rxrx-stock-analysis/"
    },
    {
     "text": "NTRA Natera, Inc. NASDAQ $412.56 +0.92%",
     "url": "https://clearank.com/stock/natera-ntra/"
    },
    {
     "text": "BIIB Biogen Inc NASDAQ $227.60 +0.55%",
     "url": "https://clearank.com/stock/biib-stock-analysis/"
    },
    {
     "text": "CI The Cigna Group NYSE $272.01 +2.45%",
     "url": "https://clearank.com/stock/cigna-group-ci/"
    },
    {
     "text": "TMO Thermo Fisher Scientific Inc. NYSE $675.00 -0.50%",
     "url": "https://clearank.com/stock/tmo-stock-analysis/"
    },
    {
     "text": "ABBV AbbVie Inc. NYSE $264.34 -0.29%",
     "url": "https://clearank.com/stock/abbvie-abbv/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "RKLB vs ASTS Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/rklb-vs-asts/"
    },
    {
     "text": "VGT vs QQQ Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vgt-vs-qqq/"
    },
    {
     "text": "AMD vs MU Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/amd-vs-mu/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "MOH Insider Trading Analysis",
   "facts": {
    "Bought": "$1.7M",
    "Sold": "$32.7M",
    "Insiders": "17",
    "Avg Transaction": "$3.1M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in MOH",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Oct 7, 2022",
       "cells": [
        "ZUBRETSKY JOSEPH M Chief Executive Officer",
        "Sell",
        "88.9K",
        "$31.1M"
       ]
      },
      {
       "label": "Oct 4, 2022",
       "cells": [
        "ZUBRETSKY JOSEPH M Chief Executive Officer",
        "Sell",
        "90.0K",
        "$30.4M"
       ]
      },
      {
       "label": "Sep 21, 2022",
       "cells": [
        "ZUBRETSKY JOSEPH M Chief Executive Officer",
        "Sell",
        "87.9K",
        "$29.8M"
       ]
      },
      {
       "label": "Apr 30, 2025",
       "cells": [
        "ZUBRETSKY JOSEPH M Chief Executive Officer",
        "Sell",
        "87.5K",
        "$28.0M"
       ]
      },
      {
       "label": "Sep 29, 2022",
       "cells": [
        "ZUBRETSKY JOSEPH M Chief Executive Officer",
        "Sell",
        "78.2K",
        "$25.9M"
       ]
      },
      {
       "label": "Sep 22, 2022",
       "cells": [
        "ZUBRETSKY JOSEPH M Chief Executive Officer",
        "Sell",
        "30.0K",
        "$9.9M"
       ]
      },
      {
       "label": "Aug 3, 2022",
       "cells": [
        "WOYS JAMES E Officer",
        "Sell",
        "25.0K",
        "$8.2M"
       ]
      },
      {
       "label": "Feb 12, 2024",
       "cells": [
        "KEIM MARK LOWELL Chief Financial Officer",
        "Sell",
        "15.0K",
        "$5.8M"
       ]
      },
      {
       "label": "Sep 8, 2022",
       "cells": [
        "BARLOW JEFF D Officer",
        "Sell",
        "14.5K",
        "$5.1M"
       ]
      },
      {
       "label": "Aug 9, 2022",
       "cells": [
        "KEIM MARK LOWELL Chief Financial Officer",
        "Sell",
        "12.0K",
        "$4.0M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Molina+Healthcare+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "What is Molina Healthcare's stock forecast for 2030?",
   "answer": "Molina Healthcare's stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $278.03. The downside scenario is $96.06, and the upside scenario reaches $804.68. These are statistical outcomes, not guarantees."
  },
  {
   "question": "Is Molina Healthcare stock a buy right now?",
   "answer": "Molina Healthcare (MOH) is currently rated Hold by Wall Street analysts, with a consensus score of 54. The median price target of $209.00 suggests limited upside from the current price of $190.86."
  },
  {
   "question": "What is the current technical outlook for Molina Healthcare stock?",
   "answer": "MOH is trading below its 50-day and 20-day moving averages, indicating a bearish short-term trend. The RSI is neutral at 42.17, but the MACD shows downward pressure, suggesting potential for further price declines towards the 200-day SMA."
  },
  {
   "question": "Are insiders buying or selling Molina Healthcare stock?",
   "answer": "Insiders are net sellers of Molina Healthcare stock, with total sales of $32.7 million compared to total purchases of $1.7 million. This activity contributes to a moderate sell signal."
  },
  {
   "question": "How does Molina Healthcare's valuation compare to its sector?",
   "answer": "Molina Healthcare's Price-to-Sales ratio of 0.23 is lower than the sector median of 3.7, but its Price-to-Earnings ratio of 1272.40 is significantly higher than the sector median of 31.9. The company's negative profit margin and ROE also lag behind sector averages."
  },
  {
   "question": "What are the key risks facing Molina Healthcare?",
   "answer": "Key risks include the company's current unprofitability, evidenced by negative profit margins and ROE, and the moderate sell signal from significant insider selling. Technical indicators also suggest near-term weakness."
  },
  {
   "question": "What are Wall Street analysts' price targets for Molina Healthcare?",
   "answer": "The median analyst price target for Molina Healthcare is $209.00, with a high of $266 and a low of $147. This implies an upside of 9.5% from the current stock price."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "CAPR",
    "name": "Capricor Therapeutics, Inc. NASDAQ",
    "price": "$8.36",
    "change": "-2.45%",
    "url": "https://clearank.com/stock/capr-stock-analysis/"
   },
   {
    "ticker": "NEOG",
    "name": "Neogen Corp. NASDAQ",
    "price": "$13.76",
    "change": "+0.73%",
    "url": "https://clearank.com/stock/neogen-neog/"
   },
   {
    "ticker": "RXRX",
    "name": "Recursion Pharmaceuticals, Inc. NASDAQ",
    "price": "$3.74",
    "change": "-3.86%",
    "url": "https://clearank.com/stock/rxrx-stock-analysis/"
   },
   {
    "ticker": "NTRA",
    "name": "Natera, Inc. NASDAQ",
    "price": "$412.56",
    "change": "+0.92%",
    "url": "https://clearank.com/stock/natera-ntra/"
   },
   {
    "ticker": "BIIB",
    "name": "Biogen Inc NASDAQ",
    "price": "$227.60",
    "change": "+0.55%",
    "url": "https://clearank.com/stock/biib-stock-analysis/"
   },
   {
    "ticker": "CI",
    "name": "The Cigna Group NYSE",
    "price": "$272.01",
    "change": "+2.45%",
    "url": "https://clearank.com/stock/cigna-group-ci/"
   },
   {
    "ticker": "TMO",
    "name": "Thermo Fisher Scientific Inc. NYSE",
    "price": "$675.00",
    "change": "-0.50%",
    "url": "https://clearank.com/stock/tmo-stock-analysis/"
   },
   {
    "ticker": "ABBV",
    "name": "AbbVie Inc. NYSE",
    "price": "$264.34",
    "change": "-0.29%",
    "url": "https://clearank.com/stock/abbvie-abbv/"
   }
  ],
  "comparisons": [
   {
    "ticker": "RKLB vs ASTS Comparison",
    "name": "",
    "url": "https://clearank.com/compare/rklb-vs-asts/"
   },
   {
    "ticker": "VGT vs QQQ Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vgt-vs-qqq/"
   },
   {
    "ticker": "AMD vs MU Comparison",
    "name": "",
    "url": "https://clearank.com/compare/amd-vs-mu/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "O",
    "text": "Realty Income Corp.",
    "url": "https://clearank.com/stock/o-stock-analysis/"
   },
   {
    "ticker": "SPG",
    "text": "Simon Property Group Inc.",
    "url": "https://clearank.com/stock/spg-stock-analysis/"
   },
   {
    "ticker": "JCI",
    "text": "Johnson Controls International",
    "url": "https://clearank.com/stock/jci-stock-analysis/"
   },
   {
    "ticker": "BLDR",
    "text": "Builders FirstSource Inc",
    "url": "https://clearank.com/stock/bldr-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "TWLO",
    "text": "↓ 7.96%",
    "url": "https://clearank.com/stock/twlo-stock-analysis/"
   },
   {
    "ticker": "CRDO",
    "text": "↑ 7.65%",
    "url": "https://clearank.com/stock/credo-crdo/"
   },
   {
    "ticker": "BLNE",
    "text": "↓ 7.40%",
    "url": "https://clearank.com/stock/blne-beeline-holdings/"
   },
   {
    "ticker": "GRT/USD",
    "text": "↑ 20.82%",
    "url": "https://clearank.com/crypto/the-graph-grt/"
   },
   {
    "ticker": "SEI/USD",
    "text": "↑ 19.29%",
    "url": "https://clearank.com/crypto/sei-sei/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "CVS",
    "text": "CVS Health",
    "url": "https://clearank.com/stock/cvs-health-cvs/"
   },
   {
    "ticker": "ELV",
    "text": "Elevance Health",
    "url": "https://clearank.com/stock/elv-stock-analysis/"
   },
   {
    "ticker": "HUM",
    "text": "Humana Inc",
    "url": "https://clearank.com/stock/hum-stock-analysis/"
   },
   {
    "ticker": "OSCR",
    "text": "Oscar Health",
    "url": "https://clearank.com/stock/oscr-stock-analysis/"
   },
   {
    "ticker": "UNH",
    "text": "UnitedHealth Group",
    "url": "https://clearank.com/stock/unitedhealth-group-unh/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/MOH-molina-healthcare-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/MOH-molina-healthcare-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "Molina Healthcare (MOH) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/moh-stock-analysis/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/moh-stock-analysis/",
        "name": "Molina Healthcare Inc. (MOH) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/moh-stock-analysis/#webpage",
     "url": "https://clearank.com/stock/moh-stock-analysis/",
     "name": "Molina Healthcare (MOH) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-23T09:31:38+00:00",
     "dateModified": "2026-09-27T05:26:20+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/MOH-molina-healthcare-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/moh-stock-analysis/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/stock/moh-stock-analysis/#richSnippet",
     "headline": "Molina Healthcare (MOH) Stock Forecast & Price Target (2026)",
     "name": "Molina Healthcare (MOH) Stock Forecast & Price Target (2026)",
     "description": "Molina Healthcare Inc. (MOH) stock: Healthcare, Healthcare Plans. $10.0B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "datePublished": "2026-07-23T09:31:38+00:00",
     "dateModified": "2026-09-27T05:26:20+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "about": {
      "@type": "Corporation",
      "name": "Molina Healthcare Inc.",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "MOH"
       },
       {
        "@type": "PropertyValue",
        "propertyID": "exchange",
        "value": "NYSE"
       }
      ],
      "description": "Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs. The company focuses on government-sponsored healthcare, offering Medicaid managed care plan",
      "tickerSymbol": "MOH",
      "sameAs": "https://www.molinahealthcare.com"
     },
     "isPartOf": {
      "@id": "https://clearank.com/stock/moh-stock-analysis/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/MOH-molina-healthcare-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/moh-stock-analysis/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "What is Molina Healthcare's stock forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Molina Healthcare's stock forecast for 2030, based on Monte Carlo simulations, projects a base case price of $278.03. The downside scenario is $96.06, and the upside scenario reaches $804.68. These are statistical outcomes, not guarantees."
     }
    },
    {
     "@type": "Question",
     "name": "Is Molina Healthcare stock a buy right now?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Molina Healthcare (MOH) is currently rated Hold by Wall Street analysts, with a consensus score of 54. The median price target of $209.00 suggests limited upside from the current price of $190.86."
     }
    },
    {
     "@type": "Question",
     "name": "What is the current technical outlook for Molina Healthcare stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "MOH is trading below its 50-day and 20-day moving averages, indicating a bearish short-term trend. The RSI is neutral at 42.17, but the MACD shows downward pressure, suggesting potential for further price declines towards the 200-day SMA."
     }
    },
    {
     "@type": "Question",
     "name": "Are insiders buying or selling Molina Healthcare stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Insiders are net sellers of Molina Healthcare stock, with total sales of $32.7 million compared to total purchases of $1.7 million. This activity contributes to a moderate sell signal."
     }
    },
    {
     "@type": "Question",
     "name": "How does Molina Healthcare's valuation compare to its sector?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Molina Healthcare's Price-to-Sales ratio of 0.23 is lower than the sector median of 3.7, but its Price-to-Earnings ratio of 1272.40 is significantly higher than the sector median of 31.9. The company's negative profit margin and ROE also lag behind sector averages."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key risks facing Molina Healthcare?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Key risks include the company's current unprofitability, evidenced by negative profit margins and ROE, and the moderate sell signal from significant insider selling. Technical indicators also suggest near-term weakness."
     }
    },
    {
     "@type": "Question",
     "name": "What are Wall Street analysts' price targets for Molina Healthcare?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The median analyst price target for Molina Healthcare is $209.00, with a high of $266 and a low of $147. This implies an upside of 9.5% from the current stock price."
     }
    }
   ]
  }
 ]
}